Anagrelide - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Anagrelide

Brand Name:

Agrylin

Strength:

0.5mg

HCPCS:

NA

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Platelet-Reducing Agent

Minor Drug Class:

PDE-3 Inhibitor

Oral (Y/N):

Yes

FDA Approval Year:

1997

FDA Discontinuation Year:

CMS Effective Date:

CMS Discontinuation Date:

Status:

In Use